Author

C. Narayana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

S. Aggarwal· 2 shared A. Chakrabarti· 1 shared A. Chakrabarty· 1 shared D. Bose· 1 shared D. Das· 1 shared K. Yadav· 1 shared L. Garg· 1 shared N. Joshi· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

S. Aggarwal

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Erythroid spectrin binding modulates peroxidase and catalase activity of heme proteins

D. Bose, S. Aggarwal, D. Das, C. Narayana, A. Chakrabarti

This study shows that spectrin binding modulates peroxidase activity of hemoglobin and other heme proteins, with implications for oxidative damage in diseases like sickle cell disease.

bioRxiv · Sep 6, 2021Biochemistry

Structural heterogeneity in biliverdin modulates spectral properties of Sandercyanin fluorescent protein

S. Ghosh, S. Mondal, K. Yadav, S. Aggarwal, W. F. Schaefer, C. Narayana, R. Subramanian

This paper reports the spectral properties and crystal structures of engineered monomeric Sandercyanin-BLA complexes, revealing how structural heterogeneity in biliverdin modulates fluorescence.

bioRxiv · Apr 2, 2021 · PreprintBioengineering

Metalloprotease Gp63 targeting novel glycoside exhibits potential antileishmanial activity

A. Chakrabarty, C. Narayana, N. Joshi, S. Garg, L. Garg, R. Sagar, S. Pati, s. singh

This study identifies a glycoside derivative, Gly 2, with potent antileishmanial activity against Leishmania donovani, targeting the metalloprotease Gp63 and showing efficacy against both visceral leishmaniasis and post-kala-azar dermal leishmaniasis.

bioRxiv · Sep 11, 2020Pharmacology & Toxicology